049180 — Cellumed Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Cellumed Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	73,188	99,918	122,085	95,553	129,140
Cost of Revenue
Gross Profit	14,326	14,362	13,631	5,632	9,489
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	72,256	91,778	123,436	121,124	157,877
Operating Profit	931	8,140	-1,351	-25,571	-28,737
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,534	9,076	-4,800	-38,581	-32,085
Provision for Income Taxes
Net Income After Taxes	618	8,259	-5,184	-37,927	-31,817
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-633	8,181	-5,571	-37,298	-31,545
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-633	8,181	-5,571	-37,298	-31,545
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-22.4	127	-157	-645	-355
Dividends per Share